New platform coming soon — AI-Based Analysis with Human-Generated Insights

Market News & Insights

American Analyst Ratings Updates: November 13th, 2026

American Analyst Ratings Updates: November 17th, 2026

Analyst Ratings Updates (USA)

Applied Aerospace & Defense (AADX) — Guggenheim lowered its price target from $30.00 to $15.00 and maintained a Buy rating.

Applied Aerospace & Defense (AADX) — Citigroup reiterated a Buy rating.

Aardvark Therapeutics (AARD) — Raymond James Financial reiterated a Market Perform rating.

Asbury Automotive Group (ABG) — Stephens downgraded its rating from Overweight to Equal Weight and has a price target of $200.00.

ACADIA Pharmaceuticals (ACAD) — Morgan Stanley lowered its price target from $28.00 to $24.00 and maintained an Equal Weight rating.

Array Digital Infrastructure (AD) — Citigroup lowered its price target from $45.00 to $43.00 and maintained a Buy rating.

Analog Devices (ADI) — Roth Capital initiated coverage with a Buy rating and set a price target of $505.00.

Autodesk (ADSK) — Loop Capital upgraded its rating from Hold to Buy and has a price target of $310.00.

Alliance Entertainment (AENT) — Noble Financial initiated coverage with a Strong Buy rating.

Agilon Health (AGL) — Zacks Research upgraded its rating from Hold to Strong Buy.

Agilon Health (AGL) — Wells Fargo raised its price target from $146.00 to $170.00 and maintained an Overweight rating.

Albany International (AIN) — Truist Financial raised its price target from $61.00 to $71.00 and maintained a Hold rating.

Arthur J. Gallagher & Co. (AJG) — Mizuho raised its price target from $302.00 to $307.00 and maintained an Outperform rating.

Alector (ALEC) — Wells Fargo initiated coverage with an Overweight rating and set a price target of $7.00.

Allegro MicroSystems (ALGM) — Roth Capital initiated coverage with a Buy rating and set a price target of $40.00.

Align Technology (ALGN) — Zacks Research upgraded its rating from Strong Sell to Hold.

Alkami Technology (ALKT) — Stephens initiated coverage with an Equal Weight rating and set a price target of $15.00.

Almonty Industries (ALM) — Stifel lowered its price target from $21.00 to $18.00 and maintained a Buy rating.

Alumis (ALMS) — HC Wainwright lowered its price target from $15.00 to $9.00 and maintained a Buy rating.

Alumis (ALMS) — Wells Fargo lowered its price target from $25.00 to $18.00 and maintained an Overweight rating.

Altimmune (ALT) — Citigroup reiterated a Market Outperform rating.

Altimmune (ALT) — B. Riley Financial reiterated a Buy rating.

Alta Equipment Group (ALTG) — DA Davidson lowered its price target from $8.00 to $6.00 and maintained a Neutral rating.

Applied Materials (AMAT) — Jefferies Financial Group lowered its price target from $770.00 to $580.00 and maintained a Buy rating.

Applied Materials (AMAT) — Needham & Company LLC lowered its price target from $580.00 to $470.00 and maintained a Buy rating.

Applied Materials (AMAT) — Bank of America lowered its price target from $650.00 to $520.00 and maintained a Buy rating.

Applied Materials (AMAT) — Stifel lowered its price target from $650.00 to $600.00 and maintained a Buy rating.

Applied Materials (AMAT) — Sanford C. Bernstein lowered its price target from $700.00 to $600.00 and maintained an Outperform rating.

Applied Materials (AMAT) — Summit Insights downgraded its rating from Buy to Hold.

Applied Materials (AMAT) — TD Securities lowered its price target from $700.00 to $500.00 and maintained a Buy rating.

Applied Materials (AMAT) — RBC reiterated an Outperform rating with a price target of $600.00.

Applied Materials (AMAT) — Wells Fargo lowered its price target from $610.00 to $500.00 and maintained an Overweight rating.

Applied Materials (AMAT) — KeyCorp reiterated an Overweight rating.

Applied Materials (AMAT) — UBS Group lowered its price target from $695.00 to $640.00 and maintained a Buy rating.

Applied Materials (AMAT) — Mizuho lowered its price target from $590.00 to $510.00 and maintained an Outperform rating.

Applied Materials (AMAT) — JPMorgan lowered its price target from $660.00 to $500.00 and maintained an Overweight rating.

AMETEK (AME) — Truist Financial reiterated a Buy rating with a price target of $316.00 ? $329.00.

Affiliated Managers Group (AMG) — Zacks Research upgraded its rating from Hold to Strong Buy.

Andersen Group (ANDG) — Robert W. Baird raised its price target from $64.00 to $71.00 and maintained an Outperform rating.

Andersen Group (ANDG) — Wells Fargo raised its price target from $49.00 to $61.00 and maintained an Equal Weight rating.

AON (AON) — Mizuho raised its price target from $363.00 to $373.00 and maintained an Outperform rating.

AON (AON) — Keefe, Bruyette & Woods raised its price target from $342.00 to $376.00 and maintained an Outperform rating.

APA (APA) — Barclays raised its price target from $44.00 to $48.00 and maintained an Equal Weight rating.

Apollo Global Management (APO) — Piper Sandler downgraded its rating from Overweight to Cautious.

Apollo Global Management (APO) — UBS Group reiterated a Buy rating with a price target of $160.00.

Aptiv (APTV) — Daiwa Securities Group downgraded its rating from Outperform to Hold and has a price target of $41.00.

Ardent Health (ARDT) — Bank of America raised its price target from $12.00 to $14.00 and maintained an Underperform rating.

Alexandria Real Estate Equities (ARE) — Bank of America downgraded its rating from Neutral to Underperform and revised its price target from $55.00 to $45.00.

Alexandria Real Estate Equities (ARE) — Jefferies Financial Group downgraded its rating from Hold to Moderate Sell.

argenex (ARGX) — Morgan Stanley lowered its price target from $1,190.00 to $1,130.00 and maintained an Overweight rating.

Arrowhead Pharmaceuticals (ARWR) — RBC reiterated an Outperform rating with a price target of $100.00.

Arrowhead Pharmaceuticals (ARWR) — Stifel lowered its price target from $104.00 to $96.00 and maintained a Buy rating.

Ascendis Pharma A/S (ASND) — HC Wainwright lowered its price target from $344.00 to $335.00 and maintained a Buy rating.

Ascendis Pharma A/S (ASND) — Canaccord Genuity Group raised its price target from $268.00 to $274.00 and maintained a Hold rating.

Ascendis Pharma A/S (ASND) — Cantor Fitzgerald raised its price target from $300.00 to $315.00 and maintained an Overweight rating.

Ascendis Pharma A/S (ASND) — RBC reiterated an Outperform rating with a price target of $290.00.

Ascendis Pharma A/S (ASND) — TD Securities raised its price target from $341.00 to $352.00 and maintained a Buy rating.

Ascendis Pharma A/S (ASND) — UBS Group raised its price target from $269.00 to $315.00 and maintained a Buy rating.

Ascendis Pharma A/S (ASND) — RBC set a price target of $352.00, with no accompanying rating specified.

Ascendis Pharma A/S (ASND) — Raymond James Financial reiterated an Outperform rating.

Ascendis Pharma A/S (ASND) — KeyCorp set a price target of $330.00, with no accompanying rating specified.

Ascendis Pharma A/S (ASND) — Wells Fargo raised its price target from $326.00 to $330.00 and maintained an Overweight rating.

Alphatec (ATEC) — HC Wainwright lowered its price target from $24.00 to $20.00 and maintained a Buy rating.

ATI (ATI) — Citigroup raised its price target from $229.00 to $240.00 and maintained a Buy rating.

ATI (ATI) — BTIG Research raised its price target from $250.00 to $260.00 and maintained a Buy rating.

Aveanna Healthcare (AVAH) — RBC reiterated an Outperform rating.

Broadcom (AVGO) — Rothschild & Co Redburn downgraded its rating from Buy to Neutral and revised its price target from $595.00 to $398.00.

Anteris Technologies Global (AVR) — Barclays lowered its price target from $10.00 to $9.00 and maintained an Equal Weight rating.

Avnet (AVT) — Bank of America lowered its price target from $115.00 to $110.00 and maintained a Neutral rating.

Axsome Therapeutics (AXSM) — Morgan Stanley lowered its price target from $249.00 to $223.00 and maintained an Equal Weight rating.

Brookfield Asset Management (BAM) — Wells Fargo raised its price target from $51.00 to $57.00 and maintained an Overweight rating.

BridgeBio Pharma (BBIO) — Morgan Stanley raised its price target from $88.00 to $91.00 and maintained an Overweight rating.

Bath & Body Works (BBWI) — UBS Group raised its price target from $17.00 to $22.00 and maintained a Neutral rating.

Better Home & Finance (BETR) — Cantor Fitzgerald changed its rating from Hold to Strong Sell.

Bilibili (BILI) — CLSA initiated coverage with a Strong Buy rating.

BJ’s Wholesale Club (BJ) — JPMorgan raised its price target from $100.00 to $113.00 and maintained a Neutral rating.

BJ’s Wholesale Club (BJ) — Wells Fargo raised its price target from $110.00 to $120.00 and maintained an Overweight rating.

BKV (BKV) — Barclays lowered its price target from $36.00 to $33.00 and maintained an Overweight rating.

Belite Bio (BLTE) — Leerink Partners raised its price target from $185.00 to $215.00 and maintained an Outperform rating.

BitMine Immersion Technologies (BMNR) — B. Riley Financial lowered its price target from $34.00 to $27.00 and maintained a Buy rating.

BioMarin Pharmaceutical (BMRN) — Morgan Stanley lowered its price target from $119.00 to $103.00 and maintained an Overweight rating.

Brookfield (BN) — RBC lowered its price target from $61.00 to $59.00 and maintained an Outperform rating.

Broadstone Net Lease (BNL) — Truist Financial raised its price target from $21.00 to $22.00 and maintained a Buy rating.

Popular (BPOP) — Hovde Group initiated coverage with a Hold rating and set a price target of $171.00.

Brown & Brown (BRO) — Mizuho raised its price target from $81.00 to $84.00 and maintained an Outperform rating.

Boost Run (BRUN) — DA Davidson has a price target of $10.00 and maintained a Buy rating.

BSR Real Estate Investment Trust (BSRT) — RBC lowered its price target from $12.50 to $11.00 and maintained a Sector Perform rating.

BSR Real Estate Investment Trust (BSRT) — Desjardins lowered its price target from $12.50 to $11.50 and maintained a Buy rating.

Bit Digital (BTBT) — Zacks Research upgraded its rating from Hold to Strong Buy.

Peabody Energy (BTU) — UBS Group initiated coverage with a Strong Buy rating.

Burlington Stores (BURL) — Wells Fargo lowered its price target from $370.00 to $330.00 and maintained an Overweight rating.

Burlington Stores (BURL) — Gordon Haskett downgraded its rating from Hold to Reduce and has a price target of $240.00.

Broadwind Energy (BWEN) — Roth Capital lowered its price target from $6.50 to $5.00 and maintained a Buy rating.

BXP (BXP) — UBS Group lowered its price target from $70.00 to $66.00 and maintained a Neutral rating.

KANZHUN (BZ) — Barclays lowered its price target from $20.00 to $17.00 and maintained an Overweight rating.

KANZHUN (BZ) — 86Research upgraded its rating from Hold to Buy and has a price target of $17.00.

Candel Therapeutics (CADL) — HC Wainwright lowered its price target from $23.00 to $18.00 and maintained a Buy rating.

Candel Therapeutics (CADL) — Stifel lowered its price target from $22.00 to $19.00 and maintained a Buy rating.

Candel Therapeutics (CADL) — Canaccord Genuity Group lowered its price target from $25.00 to $13.00 and maintained a Buy rating.

CAE (CAE) — Zacks Research upgraded its rating from Hold to Strong Buy.

Capricor Therapeutics (CAPR) — Roth Capital reiterated a Neutral rating with a price target of $7.00 ? $10.50.

Crescent Biopharma (CBIO) — HC Wainwright raised its price target from $36.00 to $40.00 and maintained a Buy rating.

Crescent Biopharma (CBIO) — Piper Sandler lowered its price target from $35.00 to $32.00 and maintained an Overweight rating.

Cerebras Systems (CBRS) — UBS Group lowered its price target from $250.00 to $155.00 and maintained a Buy rating.

Cerebras Systems (CBRS) — Needham & Company LLC lowered its price target from $300.00 to $200.00 and maintained a Buy rating.

Cerebras Systems (CBRS) — Mizuho lowered its price target from $300.00 to $240.00 and maintained an Outperform rating.

Cerebras Systems (CBRS) — Wedbush set a price target of $205.00, with no accompanying rating specified.

Cardinal Infrastructure Group (CDNL) — Truist Financial lowered its price target from $30.00 to $10.00 and maintained a Buy rating.

Codere Online Luxembourg (CDRO) — Noble Financial initiated coverage with a Strong Buy rating.

Central Puerto (CEPU) — Zacks Research upgraded its rating from Hold to Strong Buy.

CF Industries (CF) — Sanford C. Bernstein reiterated an Outperform rating.

Cigna Group (CI) — Wells Fargo raised its price target from $307.00 to $325.00 and maintained an Equal Weight rating.

Chimera Investment (CIM) — RBC lowered its price target from $13.00 to $7.00 and maintained a Sector Perform rating.

Cellebrite DI (CLBT) — JPMorgan lowered its price target from $16.00 to $15.00 and maintained an Overweight rating.

Commercial Metals (CMC) — Barclays raised its price target from $72.00 to $77.00 and maintained an Equal Weight rating.

CNX Resources (CNX) — Barclays raised its price target from $35.00 to $36.00 and maintained an Underweight rating.

Americold Realty Trust (COLD) — Piper Sandler upgraded its rating from Neutral to Overweight and revised its price target from $15.00 to $19.00.

Concentra Group Holdings Parent (CON) — Wells Fargo raised its price target from $40.00 to $48.00 and maintained an Overweight rating.

ConocoPhillips (COP) — Barclays raised its price target from $150.00 to $165.00 and maintained an Overweight rating.

California Resources (CRC) — Barclays lowered its price target from $74.00 to $68.00 and maintained an Overweight rating.

CorMedix (CRMD) — Oppenheimer reiterated an Outperform rating with a price target of $15.00 ? $13.00.

Cisco Systems (CSCO) — Citigroup lowered its price target from $139.00 to $120.00 and maintained a Buy rating.

Cisco Systems (CSCO) — Barclays lowered its price target from $123.00 to $109.00 and maintained an Equal Weight rating.

Cisco Systems (CSCO) — Truist Financial lowered its price target from $140.00 to $127.00 and maintained a Buy rating.

Cisco Systems (CSCO) — Wells Fargo lowered its price target from $150.00 to $130.00 and maintained an Overweight rating.

Cisco Systems (CSCO) — Piper Sandler reiterated a Neutral rating with a price target of $125.00 ? $112.00.

Cisco Systems (CSCO) — Rosenblatt Securities lowered its price target from $165.00 to $140.00 and maintained a Buy rating.

Canadian Solar (CSIQ) — Zacks Research upgraded its rating from Strong Sell to Hold.

Cognizant Technology Solutions (CTSH) — Deutsche Bank downgraded its rating from Buy to Hold and revised its price target from $75.00 to $66.00.

Corteva (CTVA) — RBC lowered its price target from $17.00 to $11.00 and maintained an Outperform rating.

Corteva (CTVA) — UBS Group lowered its price target from $15.00 to $10.00 and maintained a Neutral rating.

Corteva (CTVA) — Oppenheimer downgraded its rating from Outperform to Market Perform.

Corteva (CTVA) — Citigroup lowered its price target from $13.65 to $10.30 and maintained a Neutral rating.

Corteva (CTVA) — JPMorgan lowered its price target from $19.00 to $16.00 and maintained an Overweight rating.

CVRx (CVRX) — Cantor Fitzgerald has a price target of $2.00 and maintained an Overweight rating.

CVS Health (CVS) — Sanford C. Bernstein reiterated an Outperform rating.

CVS Health (CVS) — Piper Sandler set a price target of $106.00, with no accompanying rating specified.

Chevron (CVX) — Barclays raised its price target from $244.00 to $248.00 and maintained an Equal Weight rating.

Clearway Energy (CWEN) — Truist Financial raised its price target from $40.00 to $42.00 and maintained a Buy rating.

DoorDash (DASH) — Rosenblatt Securities lowered its price target from $225.00 to $210.00 and maintained a Buy rating.

Dave (DAVE) — Freedom Capital upgraded its rating from Hold to Strong Buy.

Dave (DAVE) — Freedom Broker upgraded its rating from Hold to Buy and has a price target of $350.00.

Diversified Energy (DEC) — Zacks Research downgraded its rating from Strong Buy to Hold.

Journey Medical (DERM) — B. Riley Financial reiterated a Buy rating with a price target of $15.00 ? $13.00.

Dream Finders Homes (DFH) — Zelman & Associates downgraded its rating from Outperform to Neutral.

Delek US (DK) — Mizuho lowered its price target from $83.00 to $80.00 and maintained a Neutral rating.

DICK’S Sporting Goods (DKS) — Wells Fargo raised its price target from $185.00 to $195.00 and maintained an Overweight rating.

Dolby Laboratories (DLB) — Zacks Research upgraded its rating from Strong Sell to Hold.

Digimarc (DMRC) — Needham & Company LLC reiterated a Buy rating.

Denali Therapeutics (DNLI) — Wells Fargo initiated coverage with an Overweight rating and set a price target of $35.00.

Denali Therapeutics (DNLI) — Morgan Stanley lowered its price target from $42.00 to $37.00 and maintained an Overweight rating.

Domino’s Pizza (DPZ) — Robert W. Baird upgraded its rating from Neutral to Outperform and revised its price target from $320.00 to $400.00.

Domino’s Pizza (DPZ) — BMO Capital Markets reiterated an Outperform rating.

DarioHealth (DRIO) — Stifel has a price target of $5.00 and maintained a Buy rating.

DT Midstream (DTM) — The Goldman Sachs Group upgraded its rating from Sell to Neutral and revised its price target from $121.00 to $127.00.

Devon Energy (DVN) — Barclays raised its price target from $57.00 to $59.00 and maintained an Overweight rating.

Devon Energy (DVN) — Citigroup lowered its price target from $67.00 to $60.00 and maintained a Buy rating.

Ecolab (ECL) — Wells Fargo upgraded its rating from Equal Weight to Overweight and revised its price target from $315.00 to $380.00.

Okeanis Eco Tankers (ECO) — B. Riley Financial raised its price target from $100.00 to $120.00 and maintained a Buy rating.

Okeanis Eco Tankers (ECO) — Zacks Research upgraded its rating from Hold to Strong Buy.

Eagle Financial Services (EFSI) — Freedom Broker raised its price target from $43.00 to $46.20 and maintained a Hold rating.

eHealth (EHTH) — Zacks Research downgraded its rating from Sell (E) to Sell (E+).

enGene (ENGN) — Leerink Partners upgraded its rating from Market Perform to Outperform and has a price target of $5.00.

Enlight Renewable Energy (ENLT) — Truist Financial lowered its price target from $104.00 to $102.00 and maintained a Buy rating.

Enersys (ENS) — Oppenheimer lowered its price target from $250.00 to $210.00 and maintained an Outperform rating.

Enovix (ENVX) — Craig Hallum downgraded its rating from Buy to Hold and has a price target of $2.00.

Enovix (ENVX) — B. Riley Financial downgraded its rating from Buy to Neutral and revised its price target from $9.00 to $2.00.

Enovix (ENVX) — Oppenheimer downgraded its rating from Outperform to Market Perform.

EOG Resources (EOG) — Barclays raised its price target from $155.00 to $168.00 and maintained an Equal Weight rating.

Edgewell Personal Care (EPC) — Wells Fargo raised its price target from $30.00 to $32.00 and maintained an Overweight rating.

EPR Properties (EPR) — Citigroup reiterated a Market Outperform rating.

EPR Properties (EPR) — Citizens Jmp set a price target of $70.00, with no accompanying rating specified.

Equillium (EQ) — Raymond James Financial reiterated a Strong Buy rating.

Equillium (EQ) — Jefferies Financial Group set a price target of $4.00, with a Buy rating.

EquipmentShare.com (EQPT) — Citigroup raised its price target from $23.00 to $22.00 and maintained an Overweight rating.

enCore Energy (EU) — HC Wainwright has a price target of $1.50 and maintained a Buy rating.

enCore Energy (EU) — Canaccord Genuity Group downgraded its rating from Buy to Moderate Buy and has a price target of C$1.50.

Evommune (EVMN) — Needham & Company LLC lowered its price target from $28.00 to $25.00 and maintained a Buy rating.

Exelixis (EXEL) — Morgan Stanley lowered its price target from $60.00 to $57.00 and maintained an Equal Weight rating.

National Vision (EYE) — UBS Group lowered its price target from $34.00 to $31.00 and maintained a Buy rating.

National Vision (EYE) — Barclays lowered its price target from $27.00 to $24.00 and maintained an Overweight rating.

EZCORP (EZPW) — Piper Sandler set a price target of $39.00, with no accompanying rating specified.

EZCORP (EZPW) — Canaccord Genuity Group lowered its price target from $45.00 to $44.00 and maintained a Buy rating.

EZCORP (EZPW) — Roth Capital reiterated a Buy rating with a price target of $40.00.

First American Financial (FAF) — Zacks Research downgraded its rating from Hold to Strong Sell.

Diamondback Energy (FANG) — Barclays raised its price target from $221.00 to $223.00 and maintained an Overweight rating.

Figure Technology Solutions (FIGR) — Needham & Company LLC lowered its price target from $55.00 to $50.00 and maintained a Buy rating.

Flutter Entertainment (FLUT) — Zacks Research upgraded its rating from Strong Sell to Hold.

Firefly Aerospace (FLY) — Jefferies Financial Group lowered its price target from $35.00 to $30.00 and maintained a Buy rating.

Floor & Decor (FND) — Evercore downgraded its rating from In-Line to Underperform and revised its price target from $55.00 to $45.00.

FOX (FOXA) — Morgan Stanley initiated coverage with an Overweight rating and set a price target of $90.00.

Forgent Power Solutions (FPS) — Sanford C. Bernstein lowered its price target from $48.00 to $33.00 and maintained an Outperform rating.

Forgent Power Solutions (FPS) — Robert W. Baird lowered its price target from $55.00 to $38.00 and maintained an Outperform rating.

Forgent Power Solutions (FPS) — TD Securities lowered its price target from $76.00 to $55.00 and maintained a Buy rating.

Forgent Power Solutions (FPS) — KeyCorp lowered its price target from $60.00 to $46.00 and maintained an Overweight rating.

Forgent Power Solutions (FPS) — Oppenheimer lowered its price target from $60.00 to $40.00 and maintained an Outperform rating.

fuboTV (FUBO) — B. Riley Financial lowered its price target from $18.00 to $16.00 and maintained a Buy rating.

First Watch Restaurant Group (FWRG) — Jefferies Financial Group set a price target of $20.00, with a Buy rating.

GAP (GAP) — Wells Fargo lowered its price target from $23.00 to $22.00 and maintained an Equal Weight rating.

Grid Dynamics (GDYN) — Zacks Research upgraded its rating from Hold to Strong Buy.

GH Research (GHRS) — Stifel set a price target of $38.00, with no accompanying rating specified.

Gilat Satellite Networks (GILT) — Freedom Broker lowered its price target from $18.40 to $13.30 and maintained a Buy rating.

Global-e Online (GLBE) — Piper Sandler reiterated an Overweight rating with a price target of $52.00.

Genmab A/S (GMAB) — Morgan Stanley lowered its price target from $57.00 to $56.00 and maintained an Equal Weight rating.

Global Payments (GPN) — Raymond James Financial reiterated a Market Perform rating.

Green Brick Partners (GRBK) — BTIG Research reiterated a Neutral rating.

Granite Ridge Resources (GRNT) — Freedom Broker downgraded its rating from Buy to Hold and has a price target of $7.00.

Haemonetics (HAE) — Jefferies Financial Group initiated coverage with an Overweight rating and revised its price target from $22.00 to $24.00.

Horace Mann Educators (HMN) — Zacks Research upgraded its rating from Hold to Strong Buy.

Robinhood Markets (HOOD) — The Goldman Sachs Group lowered its price target from $128.00 to $115.00 and maintained a Buy rating.

HireQuest (HQI) — DA Davidson set a price target of $22.00, with no accompanying rating specified.

Harmony Biosciences (HRMY) — Zacks Research downgraded its rating from Strong Buy to Hold.

Heartflow (HTFL) — Wells Fargo raised its price target from $39.00 to $70.00 and maintained an Overweight rating.

Heartflow (HTFL) — Stifel raised its price target from $45.00 to $70.00 and maintained a Buy rating.

Heartflow (HTFL) — Canaccord Genuity Group raised its price target from $56.00 to $69.00 and maintained a Buy rating.

Heartflow (HTFL) — Robert W. Baird raised its price target from $56.00 to $68.00 and maintained an Outperform rating.

HubSpot (HUBS) — Needham & Company LLC reiterated a Buy rating.

HubSpot (HUBS) — UBS Group set a price target of $190.00, with a Underperform rating.

Hancock Whitney (HWC) — Piper Sandler downgraded its rating from Overweight to Neutral and revised its price target from $88.00 to $71.50.

Hancock Whitney (HWC) — Stephens downgraded its rating from Strong Buy to Hold.

Hancock Whitney (HWC) — StoneX set a price target of $81.00, with no accompanying rating specified.

Hancock Whitney (HWC) — DA Davidson lowered its price target from $86.00 to $80.00 and maintained a Buy rating.

Installed Building Products (IBP) — Deutsche Bank upgraded its rating from Hold to Buy and revised its price target from $212.00 to $260.00.

i3 Verticals (IIIV) — Stephens initiated coverage with an Equal Weight rating and set a price target of $23.00.

ImageneBio (IMA) — HC Wainwright initiated coverage with a Strong Buy rating.

Immunocore (IMCR) — Morgan Stanley lowered its price target from $43.00 to $42.00 and maintained an Equal Weight rating.

Innio (INIO) — Piper Sandler initiated coverage with an Overweight rating and set a price target of $21.00.

INmune Bio (INMB) — Freedom Broker lowered its price target from $4.00 to $2.50 and maintained a Buy rating.

Jazz Pharmaceuticals (JAZZ) — Morgan Stanley raised its price target from $319.00 to $324.00 and maintained an Overweight rating.

Jefferson Capital (JCAP) — Jefferies Financial Group reiterated a Buy rating.

Keurig Dr Pepper (KDP) — Jefferies Financial Group reiterated a Hold rating.

Korn/Ferry International (KFY) — Stephens initiated coverage with an Overweight rating and set a price target of $94.00.

Kodiak Gas Services (KGS) — Wells Fargo lowered its price target from $93.00 to $66.00 and maintained an Overweight rating.

KinderCare Learning Companies (KLC) — The Goldman Sachs Group lowered its price target from $3.90 to $3.40 and maintained a Neutral rating.

Coca-Cola (KO) — Bank of America reiterated a Buy rating.

Kodiak Sciences (KOD) — UBS Group raised its price target from $120.00 to $150.00 and maintained a Buy rating.

Kite Realty Group Trust (KRG) — National Bank Financial set a price target of $28.00, with no accompanying rating specified.

Kite Realty Group Trust (KRG) — Bank of America downgraded its rating from Buy to Neutral and revised its price target from $31.00 to $28.00.

Cyclerion Therapeutics (KRSA) — Wells Fargo initiated coverage with an Overweight rating and set a price target of $44.00.

Lithium Americas (LAC) — Canaccord Genuity Group downgraded its rating from Moderate Buy to Hold.

Lithium Americas (LAC) — JPMorgan lowered its price target from $6.00 to $5.00 and maintained an Overweight rating.

Legend Biotech (LEGN) — Evercore downgraded its rating from Outperform to In-Line and has a price target of $20.00.

Levi Strauss & Co. (LEVI) — UBS Group reiterated a Buy rating.

LifeMD (LFMD) — Lake Street Capital lowered its price target from $5.00 to $3.00 and maintained a Buy rating.

LifeMD (LFMD) — Mizuho lowered its price target from $7.00 to $6.00 and maintained an Outperform rating.

Liftoff Mobile (LFTO) — Wells Fargo raised its price target from $21.00 to $27.00 and maintained an Overweight rating.

Liftoff Mobile (LFTO) — Piper Sandler raised its price target from $19.00 to $24.00 and maintained a Neutral rating.

Liftoff Mobile (LFTO) — RBC raised its price target from $35.00 to $38.00 and maintained an Outperform rating.

Liftoff Mobile (LFTO) — Barclays lowered its price target from $34.00 to $30.00 and maintained an Overweight rating.

Liftoff Mobile (LFTO) — Freedom Broker upgraded its rating from Hold to Buy and has a price target of $27.00.

Liftoff Mobile (LFTO) — Freedom Capital upgraded its rating from Hold to Buy and has a price target of $27.00.

Liftoff Mobile (LFTO) — BTIG Research raised its price target from $27.00 to $31.00 and maintained a Buy rating.

Lifevantage (LFVN) — Freedom Broker lowered its price target from $9.00 to $8.00 and maintained a Buy rating.

Lifevantage (LFVN) — UBS Group set a price target of $8.00, with no accompanying rating specified.

LGN (LGN) — Sanford C. Bernstein reiterated an Outperform rating.

LGN (LGN) — BTIG Research lowered its price target from $100.00 to $60.00 and maintained a Buy rating.

Lineage (LINE) — Piper Sandler raised its price target from $36.00 to $37.00 and maintained a Neutral rating.

Lakefront Biotherapeutics American Depositary Shares (LKFT) — TD Securities initiated coverage with a Strong Buy rating.

Lowe’s Companies (LOW) — Evercore downgraded its rating from Hold to Strong Sell.

Lowe’s Companies (LOW) — Stifel downgraded its rating from Hold to Sell and revised its price target from $195.00 to $190.00.

Liquidia (LQDA) — HC Wainwright initiated coverage with a Buy rating and set a price target of $76.00.

Intuitive Machines (LUNR) — Roth Capital lowered its price target from $30.00 to $20.00 and maintained a Buy rating.

Lyell Immunopharma (LYEL) — HC Wainwright lowered its price target from $45.00 to $39.00 and maintained a Buy rating.

Mobility Global (MBGL) — JPMorgan raised its price target from $21.00 to $25.00 and maintained a Neutral rating.

Mobility Global (MBGL) — RBC raised its price target from $23.00 to $25.00 and maintained a Sector Perform rating.

Mobility Global (MBGL) — Barclays raised its price target from $23.00 to $25.00 and maintained an Equal Weight rating.

Mobility Global (MBGL) — Robert W. Baird raised its price target from $22.00 to $26.00 and maintained a Neutral rating.

Mobility Global (MBGL) — Wells Fargo raised its price target from $23.00 to $29.00 and maintained an Overweight rating.

Mondelez International (MDLZ) — BTIG Research reiterated a Buy rating.

MiniMed Group (MMED) — Barclays lowered its price target from $22.00 to $20.00 and maintained an Equal Weight rating.

monday.com (MNDY) — Zacks Research upgraded its rating from Hold to Strong Buy.

Marathon Petroleum (MPC) — Zacks Research downgraded its rating from Strong Buy to Hold.

Marathon Petroleum (MPC) — Mizuho lowered its price target from $457.00 to $440.00 and maintained a Neutral rating.

MP Materials (MP) — Zacks Research upgraded its rating from Strong Sell to Hold.

Marker Therapeutics (MRKR) — Zacks Research downgraded its rating from Strong Buy to Hold.

Marsh & McLennan Companies (MRSH) — Mizuho raised its price target from $200.00 to $218.00 and maintained a Neutral rating.

Murphy Oil (MUR) — Barclays raised its price target from $34.00 to $35.00 and maintained an Underweight rating.

SOLV Energy (MWH) — JPMorgan raised its price target from $34.00 to $36.00 and maintained an Overweight rating.

Nebius Group (NBIS) — DA Davidson lowered its price target from $250.00 to $125.00 and maintained a Neutral rating.

Nebius Group (NBIS) — Robert W. Baird lowered its price target from $340.00 to $200.00 and maintained an Outperform rating.

Nebius Group (NBIS) — Rosenblatt Securities reiterated a Buy rating with a price target of $304.00.

Nebius Group (NBIS) — Truist Financial reiterated a Buy rating with a price target of $355.00 ? $245.00.

Neurocrine Biosciences (NBIX) — Morgan Stanley raised its price target from $185.00 to $191.00 and maintained an Equal Weight rating.

Nexxen International (NEXN) — RBC raised its price target from $13.00 to $14.00 and maintained an Outperform rating.

National Health Investors (NHI) — Bank of America downgraded its rating from Buy to Underperform and revised its price target from $86.00 to $67.00.

NIQ Global Intelligence (NIQ) — Needham & Company LLC raised its price target from $21.00 to $24.00 and maintained a Buy rating.

NIQ Global Intelligence (NIQ) — Barclays raised its price target from $24.00 to $25.00 and maintained an Overweight rating.

NIQ Global Intelligence (NIQ) — RBC raised its price target from $17.00 to $23.00 and maintained an Outperform rating.

NIQ Global Intelligence (NIQ) — Wells Fargo raised its price target from $16.50 to $22.00 and maintained an Overweight rating.

NIQ Global Intelligence (NIQ) — Bank of America set a price target of $23.00, with a Buy rating.

NIKE (NKE) — Piper Sandler reiterated a Neutral rating.

Newsmax (NMAX) — Noble Financial initiated coverage with a Strong Buy rating.

Newsmax (NMAX) — Freedom Capital upgraded its rating from Hold to Buy and has a price target of $10.00.

Newsmax (NMAX) — Freedom Broker upgraded its rating from Hold to Buy and has a price target of $10.00.

Nouveau Monde Graphite (NMG) — Freedom Broker upgraded its rating from Hold to Buy and revised its price target from $1.48 to $1.64.

NMI (NMIH) — BTIG Research lowered its price target from $54.00 to $52.00 and maintained a Buy rating.

NeuroPace (NPCE) — Cantor Fitzgerald lowered its price target from $21.00 to $12.00 and maintained an Overweight rating.

NeuroPace (NPCE) — KeyCorp lowered its price target from $18.00 to $14.00 and maintained an Overweight rating.

NeuroPace (NPCE) — Wells Fargo downgraded its rating from Overweight to Equal Weight and revised its price target from $19.00 to $9.00.

NeuroPace (NPCE) — JPMorgan downgraded its rating from Overweight to Neutral and revised its price target from $20.00 to $9.00.

NeuroPace (NPCE) — Leerink Partners downgraded its rating from Outperform to Market Perform and has a price target of $7.00.

Neptune Insurance (NP) — Mizuho lowered its price target from $33.00 to $31.00 and maintained a Neutral rating.

NerdWallet (NRDS) — Oppenheimer downgraded its rating from Outperform to Market Perform.

Intellia Therapeutics (NTLA) — Citigroup reiterated a Market Outperform rating.

Intellia Therapeutics (NTLA) — Citizens Jmp set a price target of $30.00, with no accompanying rating specified.

Netskope (NTSK) — Morgan Stanley downgraded its rating from Overweight to Equal Weight and revised its price target from $16.00 to $24.00.

NetSol Technologies (NTWK) — Noble Financial initiated coverage with a Strong Buy rating.

New Era Energy & Digital (NUAI) — Roth Capital raised its price target from $7.00 to $17.00 and maintained a Buy rating.

NU (NU) — Needham & Company LLC reiterated a Buy rating with a price target of $19.00.

NVIDIA (NVDA) — Barclays lowered its price target from $275.00 to $210.00 and maintained an Overweight rating.

NVIDIA (NVDA) — HSBC downgraded its rating from Buy to Hold and has a price target of $170.00.

NVIDIA (NVDA) — GF Securities downgraded its rating from Buy to Hold and has a price target of $188.00.

NVIDIA (NVDA) — Rosenblatt Securities lowered its price target from $390.00 to $300.00 and maintained a Buy rating.

NVIDIA (NVDA) — Wells Fargo downgraded its rating from Strong Buy to Hold.

Orchestra BioMed (OBIO) — HC Wainwright raised its price target from $10.00 to $12.00 and maintained a Buy rating.

Orchestra BioMed (OBIO) — BTIG Research raised its price target from $10.00 to $12.00 and maintained a Buy rating.

Once Upon A Farm (OFRM) — TD Securities lowered its price target from $13.00 to $10.00 and maintained a Hold rating.

Oklo (OKLO) — Truist Financial lowered its price target from $31.00 to $28.00 and maintained a Hold rating.

Omnicell (OMCL) — BTIG Research reiterated a Neutral rating.

BeOne Medicines (ONC) — Morgan Stanley raised its price target from $465.00 to $476.00 and maintained an Overweight rating.

Ondas (ONDS) — Needham & Company LLC lowered its price target from $19.00 to $14.00 and maintained a Buy rating.

Ondas (ONDS) — Rothschild & Co Redburn set a price target of $14.00, with no accompanying rating specified.

Ondas (ONDS) — Citigroup reiterated a Market Outperform rating.

Ondas (ONDS) — Lake Street Capital lowered its price target from $19.00 to $14.00 and maintained a Buy rating.

OR Royalties (OR) — Raymond James Financial issued a target update without a quoted target, with a Sell (E-) rating.

Ovintiv (OVV) — Citigroup raised its price target from $68.00 to $74.00 and maintained a Buy rating.

Ovintiv (OVV) — Barclays raised its price target from $80.00 to $85.00 and maintained an Overweight rating.

Occidental Petroleum (OXY) — Barclays raised its price target from $71.00 to $73.00 and maintained an Overweight rating.

Proficient Auto Logistics (PAL) — Stifel lowered its price target from $10.00 to $9.00 and maintained a Buy rating.

Proficient Auto Logistics (PAL) — Barrington Research lowered its price target from $12.00 to $9.00 and maintained an Outperform rating.

Palo Alto Networks (PANW) — KeyCorp upgraded its rating from Sector Weight to Overweight and has a price target of $380.00.

PAR Technology (PAR) — Stephens initiated coverage with an Equal Weight rating and set a price target of $25.00.

Par Pacific (PARR) — Mizuho lowered its price target from $91.00 to $80.00 and maintained a Neutral rating.

PepGen (PEPG) — Guggenheim raised its price target from $7.00 to $15.00 and maintained a Buy rating.

PepsiCo (PEP) — Sanford C. Bernstein reiterated an Outperform rating with a price target of $144.00.

Fidelis Insurance (PLGO) — Keefe, Bruyette & Woods raised its price target from $28.00 to $32.00 and maintained an Outperform rating.

Douglas Dynamics (PLOW) — Freedom Broker lowered its price target from $56.00 to $55.00 and maintained a Buy rating.

Plexus (PLXS) — Raymond James Financial reiterated an Outperform rating.

Power Integrations (POWI) — Roth Capital initiated coverage with a Buy rating and set a price target of $52.00.

Perpetua Resources (PPTA) — Zacks Research upgraded its rating from Strong Sell to Hold.

Porch Group (PRCH) — Zacks Research downgraded its rating from Strong Buy to Hold.

Perimeter Solutions (PRM) — Zacks Research downgraded its rating from Hold to Strong Sell.

ProQR Therapeutics (PRQR) — Citigroup reiterated a Market Outperform rating.

ProQR Therapeutics (PRQR) — Raymond James Financial reiterated a Strong Buy rating.

Paysafe (PSFE) — UBS Group lowered its price target from $7.00 to $3.50 and maintained a Sell rating.

Paysafe (PSFE) — RBC lowered its price target from $9.00 to $6.00 and maintained a Sector Perform rating.

Paysafe (PSFE) — BTIG Research downgraded its rating from Buy to Neutral.

Qiagen (QGEN) — UBS Group raised its price target from $48.00 to $50.00 and maintained a Neutral rating.

QuinStreet (QNST) — Stephens changed its rating from Hold (C-) to Hold (C).

QXO (QXO) — DA Davidson lowered its price target from $20.00 to $19.00 and maintained a Buy rating.

QXO (QXO) — KeyCorp lowered its price target from $28.00 to $19.00 and maintained an Overweight rating.

Ralliant (RAL) — Zacks Research upgraded its rating from Hold to Strong Buy.

Roblox (RBLX) — BTIG Research upgraded its rating from Strong Sell to Hold.

Roblox (RBLX) — Citigroup downgraded its rating from Buy to Neutral and has a price target of $55.00.

RingCentral (RNG) — Raymond James Financial set a price target of $8.00, with no accompanying rating specified.

Ross Stores (ROST) — Wells Fargo lowered its price target from $248.00 to $242.00 and maintained an Equal Weight rating.

Repay (RPAY) — Stephens initiated coverage with an Equal Weight rating and set a price target of $5.00.

Range Resources (RRC) — Barclays raised its price target from $42.00 to $67.00 and maintained an Equal Weight rating.

Riskified (RSKD) — The Goldman Sachs Group raised its price target from $7.50 to $9.00 and maintained a Sell rating.

Sunrun (RUN) — Wells Fargo lowered its price target from $17.00 to $14.00 and maintained an Overweight rating.

Revolution Medicines (RVMD) — Morgan Stanley lowered its price target from $272.00 to $247.00 and maintained an Overweight rating.

Ryan Specialty (RYAN) — Mizuho raised its price target from $40.00 to $48.00 and maintained a Neutral rating.

SBC Medical Group (SBC) — BTIG Research raised its price target from $8.00 to $10.00 and maintained a Buy rating.

Sally Beauty (SBH) — TD Securities raised its price target from $19.00 to $22.00 and maintained a Buy rating.

Sally Beauty (SBH) — RBC set a price target of $22.00, with no accompanying rating specified.

Service Corporation International (SCI) — Stephens changed its rating from Sell (E+) to Sell (D-).

Seadrill (SDRL) — Citigroup raised its price target from $54.00 to $55.00 and maintained a Neutral rating.

Serve Robotics (SERV) — Freedom Capital downgraded its rating from Buy to Hold and has a price target of $3.50.

Serve Robotics (SERV) — Freedom Broker downgraded its rating from Buy to Hold and has a price target of $3.50.

SEA (SE) — JPMorgan lowered its price target from $149.00 to $132.00 and maintained an Overweight rating.

Saga Communications (SGA) — Noble Financial initiated coverage with a Hold rating.

Sagimet Biosciences (SGMT) — Wells Fargo set a price target of $27.00, with no accompanying rating specified.

Sagimet Biosciences (SGMT) — Citigroup reiterated a Market Outperform rating.

Sagimet Biosciences (SGMT) — The Goldman Sachs Group reiterated a Sell rating.

Sagimet Biosciences (SGMT) — Canaccord Genuity Group lowered its price target from $56.00 to $50.00 and maintained a Buy rating.

Spyglass Pharma (SGP) — Stifel raised its price target from $42.00 to $44.00 and maintained a Buy rating.

Spyglass Pharma (SGP) — Citigroup raised its price target from $42.00 to $45.00 and maintained a Buy rating.

SiTime (SITM) — Zacks Research upgraded its rating from Hold to Strong Buy.

Snail (SNAL) — Noble Financial changed its rating from Sell (E+) to Sell (D-).

Spectrum Brands (SPB) — Raymond James Financial reiterated a Market Perform rating.

Spectrum Brands (SPB) — Canaccord Genuity Group lowered its price target from $110.00 to $105.00 and maintained a Buy rating.

SpaceX (SPCX) — KeyCorp reiterated a Sector Weight rating.

Spire Global (SPIR) — Canaccord Genuity Group lowered its price target from $22.50 to $21.50 and maintained a Buy rating.

Sound Point Meridian Capital (SPMC) — B. Riley Financial lowered its price target from $10.00 to $6.50 and maintained a Neutral rating.

Standard Nuclear (STDN) — Needham & Company LLC reiterated a Buy rating.

STERIS (STE) — Jefferies Financial Group upgraded its rating from Hold to Buy and revised its price target from $232.00 to $305.00.

STERIS (STE) — Morgan Stanley upgraded its rating from Overweight to Buy.

Sutro Biopharma (STRO) — Barclays raised its price target from $56.00 to $57.00 and maintained an Overweight rating.

STUB (STUB) — TD Securities lowered its price target from $12.00 to $10.00 and maintained a Buy rating.

Telephone and Data Systems (TDS) — Citigroup lowered its price target from $47.00 to $44.00 and maintained a Buy rating.

Tecnoglass (TGLS) — B. Riley Financial raised its price target from $55.00 to $63.00 and maintained a Buy rating.

TIM (TIMB) — Barclays raised its price target from $20.00 to $22.00 and maintained an Equal Weight rating.

TJX Companies (TJX) — Wells Fargo lowered its price target from $140.00 to $135.00 and maintained an Equal Weight rating.

TJX Companies (TJX) — Gordon Haskett downgraded its rating from Accumulate to Hold and has a price target of $130.00.

TMC the metals (TMC) — HC Wainwright lowered its price target from $11.75 to $5.50 and maintained a Buy rating.

Teekay Tankers (TNK) — Zacks Research upgraded its rating from Hold to Strong Buy.

Trustmark (TRMK) — Brean Capital downgraded its rating from Strong Buy to Hold.

Terreno Realty (TRNO) — Piper Sandler reiterated an Overweight rating.

Tractor Supply (TSCO) — Stephens downgraded its rating from Hold to Underperform.

Tractor Supply (TSCO) — Evercore downgraded its rating from Outperform to In-Line and revised its price target from $40.00 to $38.00.

Tesla (TSLA) — Glj Research reiterated a Sell rating.

Tenaris (TS) — Stifel raised its price target from $57.00 to $67.00 and maintained a Buy rating.

Tetra Tech (TTEK) — KeyCorp raised its price target from $41.00 to $42.00 and maintained an Overweight rating.

Twist Bioscience (TWST) — Robert W. Baird lowered its price target from $187.00 to $135.00 and maintained an Outperform rating.

Twist Bioscience (TWST) — TD Securities lowered its price target from $190.00 to $137.00 and maintained a Buy rating.

Twist Bioscience (TWST) — Canaccord Genuity Group lowered its price target from $205.00 to $150.00 and maintained a Buy rating.

Twist Bioscience (TWST) — Leerink Partners lowered its price target from $190.00 to $175.00 and maintained an Outperform rating.

Twist Bioscience (TWST) — RBC set a price target of $137.00, with no accompanying rating specified.

United States Antimony (UAMY) — HC Wainwright lowered its price target from $9.25 to $6.50 and maintained a Buy rating.

Ultra Clean (UCTT) — UBS Group changed its rating from Buy to Positive.

Ultra Clean (UCTT) — Barclays initiated coverage with an Equal Weight rating and set a price target of $65.00.

Ultrapar Participacoes (UGP) — Zacks Research downgraded its rating from Strong Buy to Hold.

Unisys (UIS) — Zacks Research upgraded its rating from Strong Sell to Hold.

Urban Outfitters (URBN) — UBS Group reiterated a Neutral rating.

U.S. Physical Therapy (USPH) — Barrington Research has a price target of $72.00 and maintained an Overweight rating.

Visteon (VC) — RBC raised its price target from $100.00 to $102.00 and maintained an Outperform rating.

Versigent (VGNT) — Zacks Research upgraded its rating from Strong Sell to Hold.

Controladora Vuela Compania de Aviacion (VLRS) — Zacks Research upgraded its rating from Strong Sell to Hold.

Vox Royalty (VOXR) — Roth Capital reiterated a Buy rating with a price target of $8.50 ? $8.25.

VirTra (VTSI) — Roth Capital reiterated a Buy rating with a price target of $7.50.

Vylor (VYLR) — UBS Group lowered its price target from $89.00 to $87.00 and maintained a Buy rating.

NCR Voyix (VYX) — Stephens initiated coverage with an Equal Weight rating and set a price target of $12.00.

Warner Music Group (WMG) — Morgan Stanley raised its price target from $36.00 to $39.00 and maintained an Overweight rating.

Advanced Drainage Systems (WMS) — Jefferies Financial Group initiated coverage with a Strong Buy rating.

Walmart (WMT) — Wells Fargo changed its rating from Sell (E+) to Sell (D-).

Wise Group (WSE) — UBS Group raised its price target from $17.25 to $18.00 and maintained a Buy rating.

Willis Towers Watson Public (WTW) — Mizuho raised its price target from $370.00 to $384.00 and maintained an Outperform rating.

Westwater Resources (WWR) — HC Wainwright lowered its price target from $1.50 to $1.25 and maintained a Buy rating.

Wolverine World Wide (WWW) — UBS Group raised its price target from $31.00 to $33.00 and maintained a Buy rating.

Wolverine World Wide (WWW) — Oppenheimer maintained a Market Perform rating.

Wolverine World Wide (WWW) — Williams Trading set a price target of $21.00, with no accompanying rating specified.

Wolverine World Wide (WWW) — Robert W. Baird raised its price target from $26.00 to $27.00 and maintained an Outperform rating.

Wolverine World Wide (WWW) — Stifel raised its price target from $26.00 to $28.00 and maintained a Buy rating.

Wolverine World Wide (WWW) — KeyCorp raised its price target from $25.00 to $27.00 and maintained an Overweight rating.

X-Energy (XE) — TD Securities lowered its price target from $35.00 to $25.00 and maintained a Buy rating.

Xometry (XMTR) — Rosenblatt Securities raised its price target from $130.00 to $140.00 and maintained a Buy rating.

ExxonMobil (XOM) — Barclays raised its price target from $200.00 to $206.00 and maintained an Overweight rating.

Global Medical REIT (XRN) — Zacks Research downgraded its rating from Hold to Strong Sell.

Block (XYZ) — Freedom Broker raised its price target from $105.00 to $115.00 and maintained a Buy rating.

YETI (YETI) — Citigroup lowered its price target from $53.00 to $50.00 and maintained a Buy rating.

YETI (YETI) — KeyCorp lowered its price target from $57.00 to $49.00 and maintained an Overweight rating.

YETI (YETI) — Canaccord Genuity Group lowered its price target from $46.00 to $42.00 and maintained a Hold rating.

YETI (YETI) — Roth Capital reiterated a Buy rating with a price target of $62.00 ? $52.00.

YETI (YETI) — Stifel lowered its price target from $50.00 to $48.00 and maintained a Buy rating.

YETI (YETI) — Robert W. Baird lowered its price target from $57.00 to $50.00 and maintained an Outperform rating.

YETI (YETI) — Piper Sandler downgraded its rating from Overweight to Neutral and revised its price target from $58.00 to $39.00.

York Space Systems (YSS) — Needham & Company LLC lowered its price target from $18.00 to $10.00 and maintained a Buy rating.

York Space Systems (YSS) — Piper Sandler lowered its price target from $8.00 to $7.00 and maintained a Neutral rating.

York Space Systems (YSS) — Jefferies Financial Group downgraded its rating from Buy to Hold and revised its price target from $15.00 to $6.00.

Yesway (YSWY) — Raymond James Financial reiterated an Outperform rating.

Zeta Global (ZETA) — Freedom Broker changed its rating from Sell (E+) to Sell (D-).

Zevra Therapeutics (ZVRA) — BTIG Research lowered its price target from $24.00 to $21.00 and maintained a Buy rating.

Zevra Therapeutics (ZVRA) — Cantor Fitzgerald lowered its price target from $25.00 to $19.00 and maintained an Overweight rating.

Zymeworks (ZYME) — Citizens Jmp raised its price target from $32.00 to $39.00 and maintained a Market Outperform rating.

Join the discussion

Your email address will not be published. Required fields are marked *